Fentanyl 12 Mcg Transdermal Patch For Postoperative Pain

Baskent University

Status and phase: Completed; Phase 4

Conditions: Postoperative Pain

Treatments: Drug: Fentanyl transdermal patch

Study type: Interventional

Funder types: Other

Identifiers

NCT03199157

KA14-66

Details and patient eligibility

About

The investigators designed a prospective randomized study to investigate the effect of fentanyl 12 mcg transdermal patch on postoperative pain following unilateral, single-level laminectomy/discectomy.

Enrollment: 78 patients

Sex: All

Ages: 20 to 70 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients between the ages of 20-70 years
• ASA physical status 1-2 patients undergoing single-level laminectomy/discectomy

Exclusion criteria

• A history of allergy to any study drugs
• History of opioid use, obstructive sleep apnea
• Any psychological disorders
• hepatic or renal failure

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

78 participants in 2 patient groups

Fentanyl Group

Active Comparator group

Description:

Patients received the fentanyl 12 mcg transdermal patch (FG, n=38) 8 hours preoperatively and until 24 hours after the surgery

Treatment:

Drug: Fentanyl transdermal patch

Control group

No Intervention group